Statistics for Carisma Therapeutics, - Common Stock (id:6758 CARM)
Valuation metrics
Market cap
38.29M
Enterprise value
14.39M
Trailing P/E (ttm)
-0.32
Forward P/E
-1.01
PEG ratio
-1.01
Price/Sales (ttm)
1.89
Price/Book (mrq)
-3.14
Enterprise Value/Revenue
0.71
Enterprise Value/EBITDA
-0.23
Overview
Shares outstanding
41.75M
Float
22.62M
Shares short
857.54K
% Held by insiders
0.29%
% Held by institutions
0.31%
Average volume (10 days)
243.90K
Average volume (90 days)
Price summary
52-Week low
0.80
52-Week high
3.16
52-Week change
-195.44%
Beta
50-Day moving average
0.99
200-Day moving average
1.45
Dividends and splits
Forward annual dividend rate
1.45
Forward annual dividend yield
1.72
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
March 08th, 2023
Ex-dividend date
March 08th, 2023
Last split factor
2:1
Last split date
March 08th, 2023
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
-388.30%
Operational effectiveness
Return on assets
-56.08%
Return on equity
-362.79%
Income statement
Revenue (ttm)
0.49
Revenue per share (ttm)
0.49
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-63,367,000.00
Net income to common (ttm)
-63,800,000.00
Diluted EPS (ttm)
-1.52
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
28.13M
Total cash per share (mrq)
0.67
Total debt (mrq)
3.32M
Total Debt/Equity (mrq)
-0.30
Current ratio (mrq)
323.30%
Book value per share (mrq)
-0.27
Cash flow
Cash flow statement
-67,662,000.00
Levered free cash flow (LFCF)
-41,385,752.00